Episode 69

Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Featuring perspectives from Dr Harold J Burstein and Dr Joyce O’Shaughnessy, including the following topics:

  • Introduction: ODAC — April 30, 2026 (00:00)
  • Adjuvant CDK4/6 Inhibitors (13:03)
  • Adjuvant Oral Selective Estrogen Receptor Degraders (21:53)
  • Premenopausal Patients (30:52)
  • Duration of Adjuvant Endocrine Treatment (38:44)
  • Genomic Predictors of Chemotherapy Benefit (47:19)
  • Neoadjuvant Treatment (55:13)

CME information and select publications

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for Breast Cancer Update
Breast Cancer Update
This series bridges the gap between research and patient care by providing on-going access to the perspectives and opinions of national and international breast cancer research leaders.

Listen for free